Article
Impaired HBsAg release and antiproliferative/antioxidant cell regulation by HBeAg-negative patient isolates reflects an evolutionary process.
Liver international : official journal of the International Association for the Study of the Liver - 1 Oct 2024
Basic Michael, Thiyagarajah Keerthihan, Glitscher Mirco, Schollmeier Anja, Wu Qingyan, Görgülü Esra, Lembeck Pia, Sonnenberg Jannik, Dietz Julia, Finkelmeier Fabian, Praktiknjo Michael, Trebicka Jonel, Zeuzem Stefan, Sarrazin Christoph, Hildt Eberhard, Peiffer Kai-Henrik
Abstract excerpt
BACKGROUND: The hepatitis B e antigen (HBeAg)-negative infection Phase 3 is characterized by no or minimal signs of hepatic inflammation and the absence of hepatic fibrosis. However, underlying molecular mechanisms leading to this benign phenotype are poorly understood. METHODS: Genotype A, B and D HBeAg-negative patient isolates with precore mutation G1896A from Phase 3 were analysed in comparison with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
